Clinical, Immunologic, and Molecular Factors Predicting Lymphoma Development in Sjogren's Syndrome Patients

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2007 Nov 10

PMID 17992593

Citations 23

Authors

Michael Voulgarelis

Fotini N Skopouli

Affiliations

Soon will be listed here.

Abstract

Among autoimmune diseases, Sjogren's syndrome (SS) displays the highest incidence of non-Hodgkin lymphoma (NHL) development with the salivary extranodal marginal zone B cell lymphomas being the most common type. The majority of SS-associated NHLs are characterized by localized stage, indolent clinical course, and recurrence in other extranodal sites. Although the transition from a chronic inflammatory condition to malignant lymphoma is a multistep process yet poorly understood, there is increasing evidence that chronic antigenic stimulation by an exoantigen or autoantigens plays an essential role in the development of SS associated lymphoproliferation. Additional molecular oncogenic events such as microsatellite instability, loss of the B cell cycle control, and the forced overproduction of specific B cell biologic stimulators seem to contribute to the emergence and progression of the malignant overgrowth. Among the clinical and serological parameters that have been associated with lymphoma development in SS patients, the presence of palpable purpura, low C4, and mixed monoclonal cryoglobulinemia constitute the main predictive markers, and patients displaying these risk factors should be monitored closely.

Citing Articles

Incidental Findings of Acute Myeloid Leukemia in Sjögren's Syndrome Detected by Nuclear Medicine Techniques.

Castello A, Caracciolo M, Urso L, Ortolan N, Nieri A, Panareo S Indian J Nucl Med. 2023; 37(3):279-280.

PMID: 36686298 PMC: 9855245. DOI: 10.4103/ijnm.ijnm_126_21.

Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature.

Ingravallo G, Maiorano E, Moschetta M, Limongelli L, Mastropasqua M, Agazzino G J Clin Med. 2020; 9(12).

PMID: 33321727 PMC: 7764276. DOI: 10.3390/jcm9123997.

Extraglandular ocular involvement and morbidity and mortality in primary Sjögren's Syndrome.

Mathews P, Robinson S, Gire A, Baer A, Akpek E PLoS One. 2020; 15(9):e0239769.

PMID: 32976549 PMC: 7518584. DOI: 10.1371/journal.pone.0239769.

Sjögren's Syndrome: More Than Just Dry Eye.

Akpek E, Bunya V, Saldanha I Cornea. 2019; 38(5):658-661.

PMID: 30681523 PMC: 6482458. DOI: 10.1097/ICO.0000000000001865.

Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.

Voigt A, Bohn K, Sukumaran S, Stewart C, Bhattacharya I, Nguyen C Clin Immunol. 2018; 192:58-67.

PMID: 29679709 PMC: 6941595. DOI: 10.1016/j.clim.2018.04.009.

References

Moutsopoulos H, Steinberg A, Fauci A, Lane H, Papadopoulos N . High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. J Immunol. 1983; 130(6):2663-5. View

Ihrler S, Baretton G, Menauer F, Blasenbreu-Vogt S, Lohrs U . Sjögren's syndrome and MALT lymphomas of salivary glands: a DNA-cytometric and interphase-cytogenetic study. Mod Pathol. 2000; 13(1):4-12. DOI: 10.1038/modpathol.3880002. View

Bahler D, Miklos J, Swerdlow S . Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood. 1997; 89(9):3335-44. View

Raderer M, Osterreicher C, Machold K, Formanek M, Fiebiger W, Penz M . Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol. 2001; 12(7):937-9. DOI: 10.1023/a:1011122904602. View

Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela J, Soussi T . Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997; 90(2):766-75. View

Brito-Zeron P, Ramos-Casals M, Nardi N, Cervera R, Yague J, Ingelmo M . Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients. Medicine (Baltimore). 2005; 84(2):90-97. DOI: 10.1097/01.md.0000157398.37679.47. View

Zulman J, Jaffe R, Talal N . Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med. 1978; 299(22):1215-20. DOI: 10.1056/NEJM197811302992204. View

Peng H, Chen G, Du M, Singh N, Isaacson P, Pan L . Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1996; 148(2):643-8. PMC: 1861671. View

Kong L, Ogawa N, Nakabayashi T, Liu G, DSouza E, McGuff H . Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 1997; 40(1):87-97. DOI: 10.1002/art.1780400113. View

10.

De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R . Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum. 1997; 40(2):318-31. DOI: 10.1002/art.1780400217. View

11.

Stott D, Hiepe F, Hummel M, Steinhauser G, Berek C . Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest. 1998; 102(5):938-46. PMC: 508959. DOI: 10.1172/JCI3234. View

12.

Dogan A, Du M, Koulis A, Briskin M, Isaacson P . Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1997; 151(5):1361-9. PMC: 1858078. View

13.

Miklos J, Swerdlow S, Bahler D . Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features. Blood. 2000; 95(12):3878-84. View

14.

Bohnhorst J, Thoen J, Natvig J, Thompson K . Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome. Scand J Immunol. 2001; 54(4):421-7. DOI: 10.1046/j.1365-3083.2001.00989.x. View

15.

Valesini G, Priori R, Bavoillot D, Osborn J, Danieli M, Del Papa N . Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol. 1998; 24(12):2376-80. View

16.

Gronbaek K, Straten P, Ralfkiaer E, Ahrenkiel V, Andersen M, Hansen N . Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood. 1998; 92(9):3018-24. View

17.

Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T . Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome. Lab Invest. 1999; 79(3):261-9. View

18.

Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T . The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis. 2003; 62(2):168-71. PMC: 1754442. DOI: 10.1136/ard.62.2.168. View

19.

Hsu S, Waldron Jr J, Hsu P, Hough Jr A . Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol. 1993; 24(10):1040-57. DOI: 10.1016/0046-8177(93)90183-h. View

20.

Zinzani P, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F . Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol. 1999; 17(4):1254. DOI: 10.1200/JCO.1999.17.4.1254. View